Alglucosidase alfa GZ419829
Pre-clinicalActive 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Glycogen Storage Disease Type II
Conditions
Glycogen Storage Disease Type II
Trial Timeline
Jun 10, 2021 → Oct 28, 2026
NCT ID
NCT04848779About Alglucosidase alfa GZ419829
Alglucosidase alfa GZ419829 is a pre-clinical stage product being developed by Sanofi for Glycogen Storage Disease Type II. The current trial status is active. This product is registered under clinical trial identifier NCT04848779. Target conditions include Glycogen Storage Disease Type II.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04848779 | Pre-clinical | Active |
Competing Products
20 competing products in Glycogen Storage Disease Type II